Is Transpact Enterprises a good stock to invest in?

Transpact Enterprises can be analyzed on the following key metrics - TTM P/E: 75193.8 Sector P/E: 22.38 Dividend Yield: 0% D/E ratio: -

Transpact Enterprises Share Price

Sector: Medical Equipment & Supplies

Powered by

293.80 0.00 (0.00%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 0.00

Today’s High 0.00

52 Week Low 130.60

52 Week High 350.00

Key Metrics

Market Cap (In Cr) 11.15
Beta 0.89
Div. Yield (%) 0
P/B 25.16
TTM P/E 75193.8
Sector P/E 22.38
D/E 0
Open Price 0
Prev Close 293.8

View All Metrics

Transpact Enterprises Analysis

Price Analysis

1 Week

7.62%
3 Months

51.44%
6 Month

34.46%
YTD

41.52%
1 Year

11.29%

Risk Meter

79% Low risk
79% Moderate risk
79% Balanced Risk
79% High risk
79% Extreme risk

Transpact Enterprises News

One of the advantages of the BSE Startups platform is that even startups that are not yet profitable can launch their IPOs and list on it. (Photo: Aniruddha Chowdhury/Mint)

Premium

BSE’s startups platform steps up bid to get more firms listed

2 min read . 02 Oct 2019

View More News

Transpact Enterprises Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.03

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.01

Total Operating Expense
0.08

Operating Income
0

Net Income Before Taxes
0

Net Income
0.01

Diluted Normalized EPS
0.23

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.02

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.04

Total Operating Expense
0.1

Operating Income
-0.1

Net Income Before Taxes
-0.1

Net Income
-0.09

Diluted Normalized EPS
-2.35

Period
2023

Total Revenue
0.38

Selling/ General/ Admin Expenses Total
0.11

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.11

Total Operating Expense
0.45

Operating Income
-0.06

Net Income Before Taxes
-0.07

Net Income
-0.07

Diluted Normalized EPS
-1.7

Period
2022

Total Revenue
0.15

Selling/ General/ Admin Expenses Total
0.04

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.05

Total Operating Expense
0.4

Operating Income
-0.25

Net Income Before Taxes
-0.22

Net Income
-0.22

Diluted Normalized EPS
-5.71

Period
2021

Total Revenue
0.03

Selling/ General/ Admin Expenses Total
0.03

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.05

Total Operating Expense
0.11

Operating Income
-0.09

Net Income Before Taxes
-0.06

Net Income
-0.06

Diluted Normalized EPS
-1.66

Period
2020

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.02

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.39

Total Operating Expense
0.45

Operating Income
-0.45

Net Income Before Taxes
-0.42

Net Income
-0.43

Diluted Normalized EPS
-11.21

Period
2019

Total Revenue
0.13

Selling/ General/ Admin Expenses Total
0.01

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.06

Total Operating Expense
0.42

Operating Income
-0.29

Net Income Before Taxes
-0.29

Net Income
-0.3

Diluted Normalized EPS
-3.89

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Transpact Enterprises Technical

Moving Average SMA

5 Day275.92
10 Day260.33
20 Day240

50 Day199.12
100 Day205.28
300 Day203.79

Transpact Enterprises Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Centenial Surgical Suture
147.1
-1.55
-1.04
169.5
82.15
53.66

Gkb Ophthalmics
74.97
-1.13
-1.48
131.75
59
37.84

Shree Pacetronix
74.4
0.39
0.53
245
61.11
26.46

Adeshwar Meditex
18
0
0
27.5
15
25.98

Transpact Enterprises
293.8
0
0
350
130.6
11.15

Transpact Enterprises Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

14-Nov-24
Half Yearly Results

08-Jun-24
Others

30-May-24
Audited Results

14-Mar-24
Others

13-Nov-23
Half Yearly Results

30-May-23
Audited Results

21-Oct-22
Half Yearly Results

30-May-22
Audited Results

11-Nov-21
Half Yearly Results

Meeting Date
Announced on
Purpose

25-Sept-24
09-Sept-24
AGM

30-Sept-23
21-Sept-23
AGM

29-Sept-21
07-Sept-21
AGM

View All

Company Profile

ABOUT Transpact Enterprises

Industry Medical Equipment & Supplies
ISIN INE06YD01010
BSE Code 542765

Transpact Enterprises Ltd is an India-based company, which is engaged in the primary business of dealing in shares, securities, commodities, currencies and their derivatives, stockbroker, share broker, sub-broker, authorized person, dealer, jobber, market maker, investment brokers, insurance broker, underwriter, and to carry out brokerage of all and every kind whatsoever, portfolio manager, investment advisors, mutual funds, wealth management and other related services or any other business in any other manner. Its core business is to carry on the business of consulting and advisory services on all aspects of corporate, financial and commercial matters including management consulting, debt structuring, debt advisory, project appraisals, or any related items or things, required by any person, corporate, firm or association of persons and to provide, execute and undertake related services in India or abroad.

MANAGEMENT

Komal Dwivedi Chief Financial Officer
Amrita Gupta Company Secretary and Compliance Officer
Raman Talwar Additional Executive Director

TRANSPACT ENTERPRISES SUMMARY

Transpact Enterprises is trading 0.00% lower at Rs 293.80 as compared to its last closing price. Transpact Enterprises has been trading in the price range of 0.00 & 0.00. Transpact Enterprises has given 41.52% in this year & 7.62% in the last 5 days.

Transpact Enterprises has TTM P/E ratio 75193.8 as compared to the sector P/E of 22.38.

The company posted a net profit of 0.05 Crores in its last quarter.

Listed peers of Transpact Enterprises include Centenial Surgical Suture (-1.04%), Gkb Ophthalmics (-1.48%), Shree Pacetronix (0.53%) etc.

Transpact Enterprises has a 16.16% promoter holding & 83.84% public holding.

FAQs about Transpact Enterprises

Transpact Enterprises is trading at 293.80 as on 26 Jun, 2025 4:00:01 PM. This is 0.00% lower as compared to its previous closing price of 293.8

The market capitalization of Transpact Enterprises is 11.15 Cr as on 26 Jun, 2025 4:00:01 PM.

The 52 wk high for Transpact Enterprises is 350.00 whereas the 52 wk low is 130.60

Transpact Enterprises can be analyzed on the following key metrics -

TTM P/E: 75193.8
Sector P/E: 22.38
Dividend Yield: 0%
D/E ratio: -

Transpact Enterprises reported a net profit of 0.01 Cr in 2025.

Transpact Enterprises Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Transpact Enterprises Share Price

Price Range

Key Metrics

Transpact Enterprises Analysis

Transpact Enterprises News

BSE’s startups platform steps up bid to get more firms listed

Transpact Enterprises Financials

Forecast

Forecast

Forecast

Transpact Enterprises Technical

Transpact Enterprises Peers

Transpact Enterprises Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Transpact Enterprises

MANAGEMENT

TRANSPACT ENTERPRISES SUMMARY

FAQs about Transpact Enterprises

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue